Drug recall · September 5, 2018
Calcitriol Oral Solution recall
Why: Subpotency: lower than expected potency result was obtained at the 18 month stability time point.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Calcitriol Oral Solution, 1 mcg/mL, 15 mL bottle, Rx Only, Distributed by: Ranbaxy Pharmaceuticals Inc. Jacksonville, FL 32257 USA, NDC 63304-241-59
- Lots / codes
RV1602RB, Exp 07/2019; RV1604RB, Exp 9/2019; RV1605RB, Exp 10/2019
- Quantity
- 7864 bottles
- Company
- Validus Pharmaceuticals, Inc., Parsippany, NJ
- Distribution
- U.S. nationwide
- Initiated
- June 15, 2018 · Voluntary: Firm initiated
- Classified
- September 5, 2018
- Reported
- September 5, 2018
- Ended
- January 22, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Calcitriol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.